Urine Proteins Identified by Two-Dimensional Differential Gel Electrophoresis Facilitate the Differential Diagnoses of Scrapie

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Lamoureux, Lise ^a   Simon, Sharon L R ^a   Plews, Margot ^a   Ruddat, Viola ^c   Brunet, Simone ^a   Graham, Catherine ^b   Czub, Stefanie ^b   Knox, J David ^a,d  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b CANADIAN FOOD INSPECTION AGENCY   (Canada)

^c GE HEALTHCARE   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; FLUORESCENT DYE;

ACCURACY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE MODEL; FEMALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRION; PRION DISEASE; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; SCRAPIE; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; URINALYSIS;

ALGORITHMS; ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; CARBOCYANINES; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PRINCIPAL COMPONENT ANALYSIS; PROTEINS; PROTEOME; REPRODUCIBILITY OF RESULTS; SCRAPIE;

EID: 84877956744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064044     Document Type: Article

References (51)

1. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, et al. (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11: 353-358.
2. Prusiner SB, (1991) Molecular biology of prion diseases. Science 252: 1515-1522.
3. Castilla J, Saa P, Hetz C, Soto C, (2005) In vitro generation of infectious scrapie prions. Cell 121: 195-206.
4. Saborio GP, Permanne B, Soto C, (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411: 810-813.
5. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, et al. (2007) Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 4: 645-650.
6. Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, et al. (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol 93: 438-449.
7. McGuire LI, Peden AH, Orru CD, Wilham JM, Appleford NE, et al. (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 72: 278-285.
8. Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, et al. (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6: e1001217.
9. Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, et al. (2011) Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2: e00078-11.
10. Gmitterova K, Heinemann U, Gawinecka J, Varges D, Ciesielczyk B, et al. (2009) 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases. Neurodegener Dis 6: 263-269.
11. Gmitterova K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, et al. (2009) 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol Aging 30: 1842-1850.
12. Brechlin P, Jahn O, Steinacker P, Cepek L, Kratzin H, et al. (2008) Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease. Proteomics 8: 4357-4366.
13. Cepek L, Brechlin P, Steinacker P, Mollenhauer B, Klingebiel E, et al. (2007) Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 23: 22-28.
14. Steinacker P, Klafki H, Lehnert S, Jesse S, Arnim CA, et al. (2010) ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. J Alzheimers Dis 22: 119-128.
15. Singh A, Beveridge AJ, Singh N, (2011) Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders. PLoS ONE 6: e16804.
16. Plews M, Lamoureux L, Simon SL, Graham C, Ruddat V, et al. (2011) Factors affecting the accuracy of urine-based biomarkers of BSE. Proteome Sci 9: 6.
17. Plews M, Simon SL, Boreham DR, Parchaliuk D, Wyatt H, et al. (2010) A radiation-induced adaptive response prolongs the survival of prion-infected mice3. Free Radic Biol Med 49: 1417-1421 S0891-5849(10)00465-X [pii];10.1016/j.freeradbiomed.2010.07.025 [doi].
18. Simon SL, Lamoureux L, Plews M, Stobart M, Lemaistre J, et al. (2008) The identification of disease-induced biomarkers in the urine of BSE infected cattle. Proteome Sci 6: 23.
19. Oakley H, Cole SL, Logan S, Maus E, Shao P, et al. (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26: 10129-10140.
20. Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, et al. (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44.
21. Logan DW, Marton TF, Stowers L, (2008) Species specificity in major urinary proteins by parallel evolution1. PLoS ONE 3: e3280 10.1371/journal.pone.0003280 [doi].
22. Eriksson I, Johansson E, Kettaneh Wold N, Wold S (2001) Multi- and Megavariate Data Analysis. 533.
23. Karp NA, Lilley KS, (2005) Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 5: 3105-3115.
24. Friedman DB, (2007) Quantitative proteomics for two-dimensional gels using difference gel electrophoresis. Methods Mol Biol 367: 219-239.
25. Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, et al. (2011) Human serum transthyretin levels correlate inversely with Alzheimer's disease. J Alzheimers Dis 25: 77-84.
26. Li X, Buxbaum JN, (2011) Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?1. Mol Neurodegener 6: 79 1750-1326-6-79 [pii];10.1186/1750-1326-6-79 [doi].
27. Rocha A, Lobato L, Silva H, Beirao I, Santos J, et al. (2011) Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M). Transplant Proc 43: 189-193 S0041-1345(10)01721-5 [pii];10.1016/j.transproceed.2010.11.014 [doi].
28. Velayudhan L, Killick R, Hye A, Kinsey A, Guntert A, et al. (2012) Plasma transthyretin as a candidate marker for Alzheimer's disease6. J Alzheimers Dis 28: 369-375 B2UM9868862RV120 [pii];10.3233/JAD-2011-110611 [doi].
29. Lobato L, Rocha A, (2012) Transthyretin amyloidosis and the kidney 1. Clin J Am Soc Nephrol 7: 1337-1346 CJN.08720811 [pii];10.2215/CJN.08720811 [doi].
30. Schauer-Vukasinovic V, Langen H, Giller T, (2001) Detection of immunoreactive napsin A in human urine. Biochim Biophys Acta 1524: 51-56.
31. Mori K, Shimizu H, Konno A, Iwanaga T, (2002) Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules. Arch Histol Cytol 65: 359-368.
32. Robertson DH, Cox KA, Gaskell SJ, Evershed RP, Beynon RJ, (1996) Molecular heterogeneity in the Major Urinary Proteins of the house mouse Mus musculus. Biochem J 316 (Pt 1):: 265-272.
33. Cavaggioni A, Mucignat-Caretta C, (2000) Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim Biophys Acta 1482: 218-228.
34. Hurst JL, Payne CE, Nevison CM, Marie AD, Humphries RE, et al. (2001) Individual recognition in mice mediated by major urinary proteins. Nature 414: 631-634.
35. de Bruin A, Caldelari R, Williamson L, Suter MM, Hunziker T, et al. (2007) Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris. Exp Dermatol 16: 468-475 EXD557 [pii];10.1111/j.1600-0625.2007.00557.x [doi].
36. Basora N, Tetreault MP, Boucher MP, Herring E, Beaulieu JF, (2010) Polycystin-1 is a microtubule-driven desmosome-associated component in polarized epithelial cells1. Exp Cell Res 316: 1454-1464 S0014-4827(10)00095-9 [pii];10.1016/j.yexcr.2010.02.033 [doi].
37. Delva E, Tucker DK, Kowalczyk AP, (2009) The desmosome2. Cold Spring Harb Perspect Biol 1: a002543 10.1101/cshperspect.a002543 [doi].
38. Ferone G, Mollo MR, Thomason HA, Antonini D, Zhou H, et al. (2013) p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome1. Hum Mol Genet 22: 531-543 dds464 [pii];10.1093/hmg/dds464 [doi].
39. Olivry T, Linder KE, Wang P, Bizikova P, Bernstein JA, et al. (2012) Deficient plakophilin-1 expression due to a mutation in PKP1 causes ectodermal dysplasia-skin fragility syndrome in Chesapeake Bay retriever dogs 1. PLoS One 7: e32072 10.1371/journal.pone.0032072 [doi];PONE-D-11-12807 [pii].
40. Cunningham O, Campion S, Perry VH, Murray C, Sidenius N, et al. (2009) Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation. Glia 57: 1802-1814.
41. Sheehan JJ, Zhou C, Gravanis I, Rogove AD, Wu YP, et al. (2007) Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. J Neurosci 27: 1738-1745.
42. Vincenza CM, Franco P, Vocca I, Alfano D, Longanesi-Cattani I, et al. (2009) Structure, function and antagonists of urokinase-type plasminogen activator. Front Biosci 14: 3782-3794.
43. Skrzypiec AE, Maiya R, Chen Z, Pawlak R, Strickland S, (2009) Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration. Biol Psychiatry 66: 785-794.
44. Li X, Masliah E, Reixach N, Buxbaum JN, (2011) Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? J Neurosci 31: 12483-12490.
45. Thornton E, Ziebell JM, Leonard AV, Vink R, (2010) Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury. Molecules 15: 6598-6618.
46. Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel RA, (2010) Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides 44: 145-154.
47. Sanchez D, Martinez S, Lindqvist A, Akerstrom B, Falkenberg C, (2002) Expression of the AMBP gene transcript and its two protein products, alpha(1)-microglobulin and bikunin, in mouse embryogenesis. Mech Dev 117: 293-298.
48. Suzuki M, Kobayashi H, Fujie M, Nishida T, Takigawa M, et al. (2002) Kunitz-type protease inhibitor bikunin disrupts phorbol ester-induced oligomerization of CD44 variant isoforms containing epitope v9 and subsequently suppresses expression of urokinase-type plasminogen activator in human chondrosarcoma cells. J Biol Chem 277: 8022-8032.
49. Barker R, Kehoe PG, Love S, (2011) Activators and inhibitors of the plasminogen system in Alzheimer's disease. J Cell Mol Med.
50. Lobato L, Rocha A, (2012) Transthyretin amyloidosis and the kidney1. Clin J Am Soc Nephrol 7: 1337-1346 CJN.08720811 [pii];10.2215/CJN.08720811 [doi].
51. Schauer-Vukasinovic V, Langen H, Giller T, (2001) Detection of immunoreactive napsin A in human urine 1. Biochim Biophys Acta 1524: 51-56 S0304416500001410 [pii].